Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01355224 · ClinicalTrials.gov registry record · NA
Communicating Risk Information for Obesity
A NA study of Obesity, sponsored by Boston University.
- Completed
- Registry status
- NA
- Development phase
- 798
- Enrollment target
- 1
- Study location
NCT01355224: Completed NA study of Obesity, sponsored by Boston University.
NCT01355224 is a NA study of Obesity that has completed, run by Boston University. The registered enrollment target is 798 participants, roughly in line with the 818-participant average among 1,053 other Obesity trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01355224, a NA study of Obesity, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- NA
- Development phase
- 798 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine the impact of providing genetic risk information for obesity on people's attitudes and beliefs about obesity, health behaviors and weight outcomes. Specifically, this study will examine the feasibility of using genetic information to motivate efforts to reduce obesity among individuals recruited to the Coriell Personalized Medicine Collaborative (CPMC), see below for description of CPMC.
Primary Outcome
Intention to lose 10lbs in the next 6 months was measured on a 5-point likert scale (1-strongly disagree;5-strongly agree). Responses were examined by study arm.
Conditions Studied
Interventions
- BEHAVIORAL Lifestyle
- GENETIC Genetic
Study Locations (1)
New Jersey
- Coriell Institute for Medical Research - Camden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 798 participants |
| Start Date | 2011-09 |
| Est. Completion | 2013-09 |
| Phase | NA |
What the finished NCT01355224 record still lists
NCT01355224 is an interventional study that assigns participants to a tested intervention. The registered 798 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 818-participant average among 1,053 other Obesity trials with a reported enrollment target.
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Lifestyle is the first listed.
NCT01355224 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT01355224 about?
NCT01355224 is a clinical study titled "Communicating Risk Information for Obesity". This study will examine the impact of providing genetic risk information for obesity on people's attitudes and beliefs about obesity, health behaviors and weight outcomes. Specifically, this study will examine the feasibility of using genetic information to motivate efforts to reduce obesity among i...
What is the current status of trial NCT01355224?
This trial is currently completed. It is a NA study. The enrollment target is 798 participants. The study started on 2011-09. Estimated completion is 2013-09.
What conditions does trial NCT01355224 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT01355224?
The interventions under investigation include: Lifestyle (BEHAVIORAL), Genetic (GENETIC).
Who is sponsoring clinical trial NCT01355224?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01355224 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01355224's enrollment target sits among peer trials
798 93rd of 1053 higher than 961 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06051058 · 798 participants · NA
Care Transitions App for Patients With Multiple Chronic Conditions
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia